The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
Open accessAbstract
Importance: Elevated systolic blood (SBP) pressure is a leading global health risk. Quantifying the levels of SBP is important to guide prevention policies and interventions. Objective: To estimate the association between SBP of at least 110 to 115 mm Hg and SBP of 140 mm Hg or higher and the burden of different causes of death and disability by age and sex for 195 countries and territories, 1990-2015. Design: A comparative risk assessment of health loss related to SBP. Estimated distribution of SBP was based on 844 studies from 154 countries (published 1980-2015) of 8.69 million participants. Spatiotemporal Gaussian process regression was used to generate estimates of mean SBP and adjusted variance for each age, sex, country, and year. Diseases with sufficient evidence for a causal relationship with high SBP (eg, ischemic heart disease, ischemic stroke, and hemorrhagic stroke) were included in the primary analysis. Main Outcomes and Measures: Mean SBP level, cause-specific deaths, and health burden related to SBP (≥110-115 mm Hg and also ≥140 mm Hg) by age, sex, country, and year. Results: Between 1990-2015, the rate of SBP of at least 110 to 115 mm Hg increased from 73 119 (95% uncertainty interval [UI], 67 949-78 241) to 81 373 (95% UI, 76 814-85 770) per 100 000, and SBP of 140 mm Hg or higher increased from 17 307 (95% UI, 17 117-17 492) to 20 526 (95% UI, 20 283-20 746) per 100 000. The estimated annual death rate per 100 000 associated with SBP of at least 110 to 115 mm Hg increased from 135.6 (95% UI, 122.4-148.1) to 145.2 (95% UI 130.3-159.9) and the rate for SBP of 140 mm Hg or higher increased from 97.9 (95% UI, 87.5-108.1) to 106.3 (95% UI, 94.6-118.1). For loss of DALYs associated with systolic blood pressure of 140 mm Hg or higher, the loss increased from 95.9 million (95% uncertainty interval [UI], 87.0-104.9 million) to 143.0 million (95% UI, 130.2-157.0 million) [corrected], and for SBP of 140 mm Hg or higher, the loss increased from 5.2 million (95% UI, 4.6-5.7 million) to 7.8 million (95% UI, 7.0-8.7 million). The largest numbers of SBP-related deaths were caused by ischemic heart disease (4.9 million [95% UI, 4.0-5.7 million]; 54.5%), hemorrhagic stroke (2.0 million [95% UI, 1.6-2.3 million]; 58.3%), and ischemic stroke (1.5 million [95% UI, 1.2-1.8 million]; 50.0%). In 2015, China, India, Russia, Indonesia, and the United States accounted for more than half of the global DALYs related to SBP of at least 110 to 115 mm Hg. Conclusions and Relevance: In international surveys, although there is uncertainty in some estimates, the rate of elevated SBP (≥110-115 and ≥140 mm Hg) increased substantially between 1990 and 2015, and DALYs and deaths associated with elevated SBP also increased. Projections based on this sample suggest that in 2015, an estimated 3.5 billion adults had SBP of at least 110 to 115 mm Hg and 874 million adults had SBP of 140 mm Hg or higher.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over 50% of heart disease, stroke, and heart failure are caused by increased blood pressure.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [7]
In the citing paper
“Hypertension causes over 40% of deaths in people with dia -betes 11 and is also a leading risk for fetal and maternal death in pregnancy, dementia, and renal failure (particularly in people of African ancestry) and can cause blindness.”
From São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Self-citationLim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Self-citationGlobal burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,698
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Forouzanfar, M. H., Afshin, A., Alexander, L. T., Anderson, H. R., Bhutta, Z. A., Biryukov, S., Brauer, M., Burnett, R., Cercy, K., Charlson, F. J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31679-8 · Cited by 7,698
Self-citationA Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492
Self-citationBlood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Flagged first, then by citations
Research works printed but not linked: 4
- Wright JT Jr, Bakris G, Greene T, et al; African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. JAMA. 2002;288(19):2421-2431.
- Murray CJL, Lopez AD. Global mortality, disability, and the contribution of risk factors. Lancet. 1997;349(9063):1436-1442.
- Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010. Lancet. 2012;380 (9859):2224-2260.
- Piper MA, Evans CV, Burda BU, et al. Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the US Preventive Services Task Force. Rockville (MD). US: Agency for Healthcare Research and Quality; 2014. http://www .ncbi.nlm.nih.gov/books/NBK269495/. Accessed December 17, 2015.
Cited by
Sorted by citations
Items 401–500 of 1,001
Cohen, D. D., Aroca, G., Carreño‐Robayo, J., Castañeda-Hernández, Á., Herazo-Beltrán, Y., Camacho, P. A., Otero, J. A., Martínez-Bello, D., López-López, J., & López-Jaramillo, P. A. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14621 · Cited by 31
Cao, X., Zhang, L., Wang, X., Chen, Z., Zheng, C., Chen, L., Zhou, H., Cai, J., Hu, Z., Tian, Y., et al. (2023) · BMC Public Health · doi:10.1186/s12889-023-16659-8 · Cited by 31
Cognitive impairment in cerebral small vessel disease induced by hypertension
Wei, W., Ma, D., Li, L., & Zhang, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385841 · Cited by 37
“Hypertension affects nearly one-third of the world’s population and is harmful to the brain, causing a significant global disease burden (Forouzanfar et al., 2017; Santisteban et al., 2020).”
Dependable approaches to hypertension management: A review
Elendu, C., Amaechi, D. C., Elendu, T. C., Amaechi, E. C., & Elendu, I. D. (2024) · Medicine · doi:10.1097/md.0000000000038560 · Cited by 46
“[24] Evidence-based guidelines, patient preferences, functional status, and frailty considerations should guide treat-ment decisions.”
BackgroundInfluentialLamb, S. A., Hamarneh, Y. N. A., Houle, S. K. D., Leung, A. A. C., & Tsuyuki, R. T. (2017) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163517743525 · Cited by 34
Zhang, L., Fan, F., Qi, L., Jia, J., Yang, Y., Li, J., & Zhang, Y. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1266-1 · Cited by 33
Pavúk, M., Serio, T. C., Cusack, C., Cave, M. C., Rosenbaum, P. F., & Birnbaum, L. S. (2019) · Environmental Health Perspectives · doi:10.1289/ehp5272 · Cited by 31
“Hypertension is one of the leading risk factors for death and disability globally, according to the World Health Organization Global Burden of Disease Study (Forouzanfar et al. 2017).”
Williams, B., Masi, S., Wolf, J., & Schmieder, R. E. (2020) · Cardiology and Therapy · doi:10.1007/s40119-019-00159-1 · Cited by 30
Nishigaki, N., Shimasaki, Y., Yoshida, T., & Hasebe, N. (2020) · Hypertension Research · doi:10.1038/s41440-020-0398-0 · Cited by 33
“High blood pressure (BP) is a major risk factor for cardiovascular and renal diseases [1, 2], the leading global risk factor responsible for disability-adjusted life years [3], and the second leading risk factor for adult mortality in Japan [4].”
BackgroundThe impact of changes in population blood pressure on hypertension prevalence and control in China
Fan, W., Xie, F., Wan, Y., Campbell, N. R. C., & Su, H. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13820 · Cited by 31
Prevalence and risk factors of hypertension among civil servants in Sidama Zone, south Ethiopia
Badego, B., Yoseph, A., & Astatkie, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234485 · Cited by 35
Post-surgical wireless monitoring of arterial health progression
Ruth, S. R. A., Kim, M., Oda, H., Wang, Z., Khan, Y., Chang, J., Fox, P. M., & Bao, Z. (2021) · iScience · doi:10.1016/j.isci.2021.103079 · Cited by 31
Anjos, R., Ferreira, A., Barkoudah, E., Claggett, B. L., Pinto, L. A., & Miguel, A. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpab172 · Cited by 31
Wu, S., Xu, Y., Zheng, R., Lu, J., Li, M., Chen, L., Huo, Y., Xu, M., Wang, T., Zhao, Z., et al. (2022) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2021.100350 · Cited by 31
Self-citationDhungana, R. R., Pedišić, Ž., Dhimal, M., Bista, B., & de Courten, M. (2022) · Global Health Action · doi:10.1080/16549716.2021.2000092 · Cited by 31
Hypertension and the Role of Dietary Fiber
Nepali, P., Suresh, S., Pikale, G., Jhaveri, S., Avanthika, C., Bansal, M., Islam, R., & Chanpura, A. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101203 · Cited by 38
Night Shift Work, Genetic Risk, and Hypertension
Xiao, Z., Xu, C. Y., Liu, Q., Yan, Q., Liang, J., Weng, Z., Zhang, X., Xu, J., Hang, D., & Gu, A. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.04.007 · Cited by 33
Clarke, R., Wright, N., Walters, R. G., Gan, W., Guo, Y., Millwood, I. Y., Yang, L., Chen, Y., Lewington, S., Lv, J., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20120 · Cited by 31
Self-citationThe Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers
Pietro, P. D., Izzo, C., Abate, A. C., Iesu, P., Rusciano, M. R., Venturini, E., Visco, V., Sommella, E., Ciccarelli, M., Carrizzo, A., et al. (2023) · Biomolecules · doi:10.3390/biom13010168 · Cited by 32
“Hypertension is a major cause of death and disability in Europe and in the rest of the World, responsible for an estimated 8 million deaths and 148 million disability life-years lost worldwide in 2015 [67].”
BackgroundMicrobiological Risk Assessment in Foods: Background and Tools, with a Focus on Risk Ranger
Bevilacqua, A., Santis, A. D., Sollazzo, G., Speranza, B., Racioppo, A., Sinigaglia, M., & Corbo, M. R. (2023) · Foods · doi:10.3390/foods12071483 · Cited by 31
“One of the most important tools is the Disability-Adjusted Life Year (DALY), which indicates the time lived in a disabled condition or the time lost because of an early death caused by the assessed risks [29].”
MethodFugger, G., Dold, M., Bartova, L., Kautzky, A., Souery, D., Mendlewicz, J., Serretti, A., Zohar, J., Montgomery, S., Frey, R., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.03.005 · Cited by 33
Leszto, K., Biskup, L., Korona, K., Marcinkowska, W., Możdżan, M., Węgiel, A., Młynarska, E., Rysz, J., & Franczyk, B. (2024) · Antioxidants · doi:10.3390/antiox13060688 · Cited by 31
“Hypertension stands as a significant global health concern, as it is a leading cause of mortality worldwide, accounting for around 14% of all deaths [62].”
BackgroundKogure, M., Hirata, T., Nakaya, N., Tsuchiya, N., Nakamura, T., Narita, A., Miyagawa, K., Koshimizu, H., Obara, T., Metoki, H., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0335-2 · Cited by 31
“The prevention of hypertension is very important because hypertension leads to serious diseases, such as heart disease and stroke [1].”
BackgroundTocci, G., Presta, V., Ferri, C., Redón, J., & Volpe, M. (2020) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-020-00359-0 · Cited by 30
“Poor rates of blood pressure (BP) control have relevant socio-economic consequences, as well as important health implications, considering that elevated BP accounts for more than 54% of deaths from ischemic heart disease at world level [5].”
BackgroundBlood Pressure States Transition Inference Based on Multi-State Markov Model
Yang, J., Liu, F., Wang, B., Chen, C., Church, T. R., Dukes, L., & Smith, J. O. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.3006217 · Cited by 30
Hussen, F. M., Adem, H. A., Roba, H. S., Mengistie, B., & Assefa, N. (2020) · SAGE Open Medicine · doi:10.1177/2050312120974145 · Cited by 31
Shen, Q., Xu, Q., Li, G., Ren, L., Zhang, Z., Zhang, Y., Zhong, Z., Li, X., & Wang, Q. (2021) · Environmental Health · doi:10.1186/s12940-021-00803-1 · Cited by 30
Jayawardana, N. W. I. A., Jayalath, W. A. T. A., Madhujith, W. M. T., Ralapanawa, U., Jayasekera, R. S., Alagiyawanna, S. A. S. B., Bandara, A. M. K. R., & Kalupahana, N. S. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0600-8 · Cited by 30
Wallace, I. J., Felson, D. T., Worthington, S., Duryea, J., Clancy, M. M., Aliabadi, P., Eick, G. N., Snodgrass, J. J., Baggish, A. L., & Lieberman, D. E. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215886 · Cited by 31
Shen, Y. H., Dai, Y., Wang, X. Q., Zhang, R., Lu, L., Ding, F. H., & Shen, W. F. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0959-1 · Cited by 32
“Background Epidemiologic studies have shown that hypertension and type 2 diabetes mellitus (T2DM) are global public health issues and become the major cause of disease burden and mortality [1, 2].”
BackgroundSatoh, M., Maeda, T., Hoshide, S., & Ohkubo, T. (2019) · Hypertension Research · doi:10.1038/s41440-019-0221-y · Cited by 28
Self-citationUnique characteristics of Asians with hypertension: what is known and what can be done?
Loo, G. J. M., Puar, T. H. K., Foo, R., Ong, T. K., Wang, T., Nguyen, Q. N., Chin, C. T., & Chin, C. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003706 · Cited by 41
“Of note, about 30% of burden related to hypertension occurred in individuals with well controlled BP between 115 and 140mmHg [2].”
BackgroundInfluentialfor COBRA-BPS Study Group, Jafar, T. H., Jehan, I., de Silva, H. A., Naheed, A., Gandhi, M., Assam, P. N., Finkelstein, E. A., Quigley, H. L., Bilger, M., et al. (2017) · Trials · doi:10.1186/s13063-017-2018-0 · Cited by 31
Dhungana, R. R., Khanal, M. K., Joshi, S., Kalauni, O. P., Shakya, A., Bhrutel, V., Panthi, S., Ramesh Kumar, K. C., Ghimire, B., Pandey, A. R., et al. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2275-9 · Cited by 30
Joint UK societies’ 2019 consensus statement on renal denervation
Lobo, M. D., Sharp, A. S. P., Kapil, V., Davies, J. E., de Belder, M., Cleveland, T., Bent, C. L., Chapman, N., Dasgupta, I., Levy, T., et al. (2019) · Heart · doi:10.1136/heartjnl-2019-315098 · Cited by 29
Satoh, M., Metoki, H., Asayama, K., Murakami, T., Inoue, R., Tsubota‐Utsugi, M., Matsuda, A., Hirose, T., Hara, A., Obara, T., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012121 · Cited by 29
Self-citationMarinier, K., Macouillard, P., Champvallins, M. D., Deltour, N., Poulter, N. R., & Mancia, G. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4884 · Cited by 31
Patient perspectives on hypertension management in health system of Sri Lanka: a qualitative study
Perera, M. N., de Silva, C. K., Tavajoh, S., Kasturiratne, A., Luke, N. V., Ediriweera, D. S., Ranasinha, C. D., Legido‐Quigley, H., de Silva, H. A., & Jafar, T. H. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031773 · Cited by 29
Mokadem, M. E., Boshra, H., Hady, Y. A. A. E., Kasla, A., & Gouda, A. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0286-8 · Cited by 29
Francisco, S. C., Araújo, L. F., Griep, R. H., Chor, D., Molina, M. D. C. B., Mil, J. G., Benseñor, I. M., Matos, S. M. A., Barreto, S. M., & Giatti, L. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520000124 · Cited by 33
Najafipour, H., Nasri, H., Rostamzadeh, F., Amirzadeh, R., Shadkam, M., & Mirzazadeh, A. (2020) · Journal of Human Hypertension · doi:10.1038/s41371-020-00392-5 · Cited by 28
He, J., Huang, J., Li, C., Chen, J., Lu, X., Chen, J.-C., He, H., Li, J., Cao, J., Chen, C.-S., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16758 · Cited by 31
Song, T., Liu, F., Deng, N., Qian, S., Cui, T., Guan, Y., Arnolda, L., Zhang, Z., & Yu, P. (2021) · Journal of Medical Internet Research · doi:10.2196/25522 · Cited by 32
“In 2015, an estimated 1.13 billion people worldwide had hypertension, leading to 19% of global deaths [2,3].”
InfluentialHickey, M. D., Ayieko, J., Owaraganise, A., Sim, N., Balzer, L. B., Kabami, J., Atukunda, M., Opel, F. J., Wafula, E. M., Nyabuti, M., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003803 · Cited by 29
“Hypertension is the most important risk factor for cardiovascular disease (CVD) and accounts for 14% of global mortality [1].”
Seaks, C. E., Weekman, E. M., Sudduth, T. L., Xie, K., Wasek, B., Fardo, D. W., Johnson, L. A., Bottiglieri, T., & Wilcock, D. M. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211069006 · Cited by 30
A History of Population Health
Mackenbach, J. P. (2020) · BRILL eBooks · doi:10.1163/9789004429130 · Cited by 50
Management of arterial hypertension: Challenges and opportunities
da Silva, B. V. S., Sousa, C., Caldeira, D., Abreu, A., & Pinto, F. J. (2022) · Clinical Cardiology · doi:10.1002/clc.23938 · Cited by 43
Martín‐Fernández, J., Alonso‐Safont, T., Polentinos-Castro, E., Esteban-Vasallo, M. D., Ariza-Cardiel, G., Anglada, M. I. G., Perruca, L. S., Rodríguez-Martínez, G., del Campo, R. R., & Bilbao‐González, A. (2023) · BMC Family Practice · doi:10.1186/s12875-023-02036-2 · Cited by 29
Zhou, L., He, L., Kong, Y., Lai, Y., Dong, J., & Ma, C. (2023) · Journal of Clinical Hypertension · doi:10.1111/jch.14690 · Cited by 30
Care Cascades for Hypertension in Low-Income Settings: A Systematic Review and Meta-Analysis
Lamloum, D., Fassio, F., Osetinsky, B., & Tediosi, F. (2023) · International Journal of Public Health · doi:10.3389/ijph.2023.1606428 · Cited by 29
“Subgroups analysis considered Gross National Income (GNI), geographical area and time period before-after 2015 [24].”
Liu, A., Lin, Y.-X., Meng, T., Tian, P., Chen, J., Zhang, X., Xu, W.-H., Zhang, Y., Zhang, D., Zheng, Y., et al. (2024) · Journal of Global Health · doi:10.7189/jogh.14.04172 · Cited by 28
“It affects approximately 31% of the global adult population (around 1.4 billion) and is characterised by a rising prevalence which expected to exceed 1.6 billion by 2025 [1,3].”
BackgroundInfluentialAcute Cardiovascular Responses after a Single Bout Blood Flow Restriction Training
Martínez, M. P., Medrano, I. C., Cortell-Tormo, J. M., Tortosa, J., Alkhadar, Y., Sanchís, J., & Laurentino, G. C. (2018) · International journal of exercise science · doi:10.70252/opqk2380 · Cited by 29
Implementing ABPM into Clinical Practice
Hinderliter, A. L., Voora, R. A., & Viera, A. J. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0805-y · Cited by 29
Age-related comorbidities and mortality in people living with HIV in rural Tanzania
Albrecht, S., Franzeck, F. C., Mapesi, H., Hatz, C., Kalinjuma, A. V., Glass, T. R., Mnzava, D., Letang, E., Paris, D. H., Battegay, M., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002171 · Cited by 28
“factor for cardiovascular disease [32].”
Chen, H.-Y., & Chauhan, S. P. (2019) · International Journal of Cardiology Hypertension · doi:10.1016/j.ijchy.2019.100007 · Cited by 28
Kibria, G. M. A., Nemirovsky, A., Sharmeen, A., & Day, B. F. (2019) · Hypertension Research · doi:10.1038/s41440-019-0275-x · Cited by 26
Adane, E., Atnafu, A., & Aschalew, A. Y. (2020) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s234674 · Cited by 28
Gill, D., Georgakis, M. K., Zuber, V., Karhunen, V., Burgess, S., Malik, R., & Dichgans, M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016773 · Cited by 27
Sala, L. L., Crestani, M., Garavelli, S., de Candia, P., & Pontiroli, A. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010143 · Cited by 29
Hussain, A., Mahmood, F., Arshad, M. S., Abbas, N. A., Qamar, N., Mudassir, J., Farhaj, S., Nirwan, J. S., & Ghori, M. U. (2020) · Polymers · doi:10.3390/polym12123057 · Cited by 28
Neufcourt, L., Zins, M., Berkman, L. F., & Grimaud, O. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002959 · Cited by 28
O’Driscoll, J. M., Edwards, J. J., Coleman, D. A., Taylor, K. A., Sharma, R., & Wiles, J. D. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003269 · Cited by 29
Chen, X., Liu, S. J., Chu, J., Hu, W., Sun, N., & Shen, Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.919506 · Cited by 30
Road Traffic Noise and Incidence of Primary Hypertension
Huang, J., Yang, T., Gulliver, J., Hansell, A., Mamouei, M., Cai, Y. S., & Rahimi, K. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100262 · Cited by 28
Borah, P. K., Kalita, H. C., Paine, S. K., Khaund, P., Bhattacharjee, C. K., Hazarika, D., Sharma, M., & Mahanta, J. (2017) · Indian Heart Journal · doi:10.1016/j.ihj.2017.08.008 · Cited by 29
Kibria, G. M. A., Swasey, K. K., Sharmeen, A., Sakib, M. N., & Burrowes, V. J. (2018) · Health Science Reports · doi:10.1002/hsr2.83 · Cited by 27
“Over the last few decades, the prevalence of hypertension and other non‐communicable diseases has increased at an alarming rate in developing countries due to the epidemiologic and demographic transitions in these countries.(2,3) Moreover, many developing countries are currently dealing with a problem that is also kno…”
BackgroundA systematic review of hypertension and stress-the silent killers
Balwan, W. K., & Kour, S. (2021) · Scholars Academic Journal of Biosciences · doi:10.36347/sajb.2021.v09i06.002 · Cited by 27
“Though researchers aren‟t sure whether repeated spikes in blood pressure from lasting (chronic) stress cause high blood pressure (Fuster, 2017).”
BackgroundNatural Compounds for Preventing Age-Related Diseases and Cancers
Ki, M., Youn, S., Kim, D. H., & Pack, S. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147530 · Cited by 30
Risk stratification of sudden cardiac death in hypertension
Tereshchenko, L., Soliman, E., Davis, B., & Oparil, S. (2017) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2017.08.012 · Cited by 22
“8 million deaths and 143 million disability-adjusted-life-years were estimated to be related to SBP of 140 mmHg or higher[13].”
BackgroundGaudieri, V., Acampa, W., Rozza, F., Nappi, C., Zampella, E., Assante, R., Mannarino, T., Mainolfi, C. G., Petretta, M., Verberne, H. J., et al. (2019) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jez025 · Cited by 27
Zhou, Y., Jia, L., Lu, B., Gu, G., Hu, H., Zhang, Z., Bai, L., & Cui, W. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13564 · Cited by 27
Wang, C., Wang, C., Liu, S., Chen, Z., & Liu, S. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01530-0 · Cited by 27
Bhagavathula, A. S., Shah, S. M. A., & Aburawi, E. H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312693 · Cited by 27
Marklund, M., Tullu, F. T., Thout, S. R., Yu, J., Brady, T. M., Appel, L. J., Neal, B. C., Wu, J. H. Y., & Gupta, R. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19072 · Cited by 26
Self-citationHan, C., Qian, X., Ren, X., Zhang, S., Hu, L., Li, J., Huang, Y., Huang, R., Ooi, K., Lin, H. Q., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02994-1 · Cited by 28
Martínez, R., Soliz, P. N., Campbell, N. R. C., Lackland, D. T., Whelton, P. K., & Ordúñez, P. (2022) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2022.143 · Cited by 27
“Suboptimal blood pressure (BP) control is the most important population attributable risk factor (PAF) for CVD and stroke, including hemorrhagic (PAF=58%) and ischemic (50%) stroke, ischemic heart disease (55%), and for other forms of CVD (58%) (7).”
BackgroundChuka, A., Gutema, B. T., Ayele, G., Degefa, N., Aschalew, Z., & Hailu, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237333 · Cited by 29
“In addition, there were 143 million Disability-adjusted life years due to high blood pressure [13].”
BackgroundGlobal Burden of Disease Attributable to Hypertension
Cooper, R., Kaufman, J. S., & Bovet, P. (2017) · JAMA · doi:10.1001/jama.2017.4213 · Cited by 27
Blood pressure measurement in special populations and circumstances
Stergiou, G. S., Dolan, E., Kollias, A., Poulter, N. R., Shennan, A., Staessen, J. A., Zhang, Z., & Weber, M. A. (2018) · The Journal of Clinical Hypertension · doi:10.1111/jch.13296 · Cited by 29
Javidi, M., Ahmadizad, S., Argani, H., Najafi, A., Ebrahim, K., Salehi, N., Javidi, Y., Pescatello, L. S., Jowhari, A., & Hackett, D. A. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9090287 · Cited by 36
Chuang, S., Chang, H., Cheng, H., Pan, W., & Chen, C. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx178 · Cited by 26
Autonomic Differentiation Map: A Novel Statistical Tool for Interpretation of Heart Rate Variability
Lucini, D., Solaro, N., & Pagani, M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00401 · Cited by 26
“The burden of chronic conditions, such as obesity (Christakis and Fowler, 2007) or hypertension (Forouzanfar et al., 2017), is continuously growing worldwide and represents an important barrier to modernization in developing countries.”
BackgroundImoun, S., Kotruchin, P., Thinsug, P., Mitsungnern, T., Techa-atik, P., & Pongchaiyakul, C. (2018) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.05.014 · Cited by 26
Wake, A. D., Mengistu, D., & Tuji, T. S. (2020) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s242123 · Cited by 26
Rauniyar, S. K., Rahman, M. M., Rahman, M. S., Abe, S. K., Nomura, S., & Shibuya, K. (2020) · BMC Public Health · doi:10.1186/s12889-020-09450-6 · Cited by 27
Lombardi, C., Sharman, J. E., Padwal, R. S., Picone, D. S., Alcolea, E., Ayala, R., Gittens, A., Lawrence-Williams, P., Malcolm, T., Ojeda, C. N., et al. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.14058 · Cited by 25
Zanaty, M., Seara, F. D. A. C., Nakagawa, P., Deng, G., Mathieu, N. M., Balapattabi, K., Karnik, S. S., Grobe, J. L., & Sigmund, C. D. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15793 · Cited by 26
Sujarwoto, S., & Maharani, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244333 · Cited by 26
Lin, X., Du, Z., Liu, Y., & Hao, Y. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.145707 · Cited by 26
Concentrations of vanadium in urine with hypertension prevalence and blood pressure levels
Jiang, S., Zhou, S., Liu, H., Peng, C., Zhang, X., Zhou, H., Wang, Z., & Lü, Q. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112028 · Cited by 26
Lydia, A., Setiati, S., Soejono, C. H., Istanti, R., Marsigit, J., & Azwar, M. K. (2021) · BMC Public Health · doi:10.1186/s12889-021-10544-y · Cited by 31
Li, C., Chen, K., Cornelius, V. R., Tomeny, E., Wang, Y., Yang, X., Yuan, X., Qin, R., Yu, D., Wu, Z., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003515 · Cited by 26
Aydın, C., Alpsoy, Ş., Akyüz, A., Gür, D. Ö., Emlek, N., Şahin, A., Gültekin, A., & Aykaç, H. (2021) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000560 · Cited by 19
Isometric Handgrip as an Adjunct for Blood Pressure Control: a Primer for Clinicians
McGowan, C. L. M., Proctor, D. N., Swaine, I., Brook, R. D., Jackson, E. A., & Levy, P. D. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0748-8 · Cited by 26
Kunutsor, S. K., Kieneker, L. M., Bakker, S. J. L., James, R. W., & Dullaart, R. P. F. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.353 · Cited by 26
“To avoid double counting of the hypertension burden, studies of the global and national burden of risk factors now base their data on SBP measurements due to the strong correlation between SBP and DBP.44 Moreover, SBP has been considered to be a better predictor of health outcomes than DBP.45 Given this, we conducted…”
BackgroundBhasin, M., Denninger, J. W., Huffman, J. C., Joseph, M. G., Niles, H. F., Chad‐Friedman, E., Goldman, R. E., Buczynski, B., Mahoney, B. A., Fricchione, G. L., et al. (2018) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2017.0053 · Cited by 26
Cao, X., Broughton, S. T., Waits, G. S., Nguyen, T., Li, Y., & Soliman, E. Z. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.10.006 · Cited by 26
Sterpetti, A. V., Gabriele, R., Sapienza, P., di Marzo, L., & Borrelli, V. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102384 · Cited by 25
Ofori, S., & Obosi, J. (2019) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2019.100899 · Cited by 25
“The Global Burden of Disease report published in 2017 identified hypertension as one of the world's leading cause of disability and death (Forouzanfar et al., 2017).”
BackgroundSi, S., Li, H., & Xiao, H. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101422 · Cited by 25
Metadata
- Authors
- Forouzanfar, M. H., Liu, P., Roth, G. A., Ng, M., Biryukov, S., Marczak, L., Alexander, L., Estep, K., Hassen Abate, K., Akinyemiju, T. F., Ali, R., Alvis-Guzman, N., Azzopardi, P., Banerjee, A., Bärnighausen, T., Basu, A., Bekele, T., Bennett, D. A., Biadgilign, S., Catalá-López, F., Feigin, V. L., Fernandes, J. C., Fischer, F., Gebru, A. A., Gona, P., Gupta, R., Hankey, G. J., Jonas, J. B., Judd, S. E., Khang, Y.-H., Khosravi, A., Kim, Y. J., Kimokoti, R. W., Kokubo, Y., Kolte, D., Lopez, A., Lotufo, P. A., Malekzadeh, R., Melaku, Y. A., Mensah, G. A., Misganaw, A., Mokdad, A. H., Moran, A. E., Nawaz, H., Neal, B., Ngalesoni, F. N., Ohkubo, T., Pourmalek, F., Rafay, A., Rai, R. K., Rojas-Rueda, D., Sampson, U. K., Santos, I. S., Sawhney, M., Schutte, A. E., Sepanlou, S. G., Shifa, G. T., Shiue, I., Tedla, B. A., Thrift, A. G., Tonelli, M., Truelsen, T., Tsilimparis, N., Ukwaja, K. N., Uthman, O. A., Vasankari, T., Venketasubramanian, N., Vlassov, V. V., Vos, T., Westerman, R., Yan, L. L., Yano, Y., Yonemoto, N., Zaki, M. E. S., & Murray, C. J. L.
- Affiliations
- University of Washington (US)
- Jimma University, Jimma, Ethiopia
- University of Alabama at Birmingham (US)
- University of Oxford (GB)
- Universidad de Cartagena, Cartagena de Indias, Colombia
- South Australian Health and Medical Research Institute (AU)
- Farr Institute (GB)
- Harvard University (US)
- University of Canterbury (NZ)
- Madda Walabu University (ET)
- Independent Public Health Consultants, Addis Ababa, Ethiopia
- Universitat de València (ES)
- Auckland University of Technology (NZ)
- Pharmacology and Experimental Therapeutics, IBILI - Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, University of Coimbra, Coimbra, Portugal
- Bielefeld University (DE)
- Mekelle University (ET)
- University of Massachusetts Boston (US)
- Eternal Hospital (IN)
- The University of Western Australia (AU)
- Heidelberg University (DE)
- Seoul National University (KR)
- Ministry of Health and Medical Education (IR)
- Southern University College (MY)
- Simmons University (US)
- National Cerebral and Cardiovascular Center (JP)
- Brown University (US)
- University of Melbourne, Melbourne School of Population and Global Health, Melbourne, QLD, Australia
- Universidade de São Paulo (BR)
- Digestive Disease Research Institute (IR)
- The University of Adelaide (AU)
- National Institutes of Health (US)
- Columbia University (US)
- SIU Medicine (US)
- The University of Sydney (AU)
- Ministry of Health and Social Welfare (TZ)
- Teikyo University (JP)
- University of British Columbia (CA)
- Contech School of Public Health, Lahore, Punjab, Pakistan
- Society for Health and Demographic Surveillance, Suri, India
- ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain
- Marshall University (US)
- South African Medical Research Council (ZA)
- Southern Nations, Nationalities, and Peoples' Region (ET)
- Northumbria University (GB)
- James Cook University (AU)
- Monash Health (AU)
- University of Calgary (CA)
- University of Copenhagen (DK)
- Universität Hamburg (DE)
- Federal Teaching Hospital Abakaliki (NG)
- University of Warwick (GB)
- Urho Kaleva Kekkonen Institute (FI)
- Raffles Neuroscience Centre, Raffles Hospital, Singapore, Singapore
- National Research University Higher School of Economics, Moscow, Russia
- Federal Institute for Population Research (DE)
- Duke Kunshan University (CN)
- Northwestern University (US)
- National Center of Neurology and Psychiatry (JP)
- Mansoura University (EG)
- Corresponding author
- Murray, Christopher J. L.
- ORCID
- Forouzanfar, Mohammad H.
- Liu, Patrick
- Roth, Gregory A.
- Ng, Marie
- Marczak, Laurie
- Alexander, Lily
- Akinyemiju, Tomi F.
- Ali, Raghib
- Azzopardi, Peter
- Banerjee, Amitava
- Bärnighausen, Till
- Basu, Arindam
- Bennett, Derrick A.
- Biadgilign, Sibhatu
- Catalá-López, Ferrán
- Feigin, Valery L.
- Fischer, Florian
- Gona, Philimon
- Gupta, Rajeev
- Hankey, Graeme J.
- Jonas, Jost B.
- Judd, Suzanne E.
- Khang, Young-Ho
- Khosravi, Ardeshir
- Kim, Yun Jin
- Kimokoti, Ruth W.
- Kokubo, Yoshihiro
- Kolte, Dhaval
- Lotufo, Paulo A.
- Melaku, Yohannes Adama
- Mensah, George A.
- Misganaw, Awoke
- Mokdad, Ali H.
- Moran, Andrew E.
- Neal, Bruce
- Ohkubo, Takayoshi
- Pourmalek, Farshad
- Santos, Itamar S.
- Schutte, Aletta E.
- Sepanlou, Sadaf G.
- Shifa, Girma Temam
- Shiue, Ivy
- Tedla, Bemnet Amare
- Thrift, Amanda G.
- Tonelli, Marcello
- Tsilimparis, Nikolaos
- Ukwaja, Kingsley Nnanna
- Uthman, Olalekan A.
- Vasankari, Tommi
- Venketasubramanian, Narayanaswamy
- Vos, Theo
- Westerman, Ronny
- Yan, Lijing L.
- Yano, Yuichiro
- Yonemoto, Naohiro
- Zaki, Maysaa El Sayed
- Murray, Christopher J. L.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2017-01-10
- Volume
- 317
- Issue
- 2
- Pages
- 165
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2572331255
- Cited by
- 2,381
- References
- 56
- Citations by year
- 2026: 120 · 2025: 186 · 2024: 280 · 2023: 329 · 2022: 323 · 2021: 320 · 2020: 308 · 2019: 264 · 2018: 166 · 2017: 78
- FWCI
- 172.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion)
- ResearchOnline at James Cook University (James Cook University) (submittedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- UCL Discovery (University College London) (submittedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Northumbria Research Link (Northumbria University) (submittedVersion)
- PUB – Publications at Bielefeld University (Bielefeld University) (submittedVersion)
- Publikationen an der Universität Bielefeld (Universität Bielefeld) (submittedVersion)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Bill and Melinda Gates Foundation
- Omron Healthcare
- National Institute for Health and Care Research (CL-2010-09-002)
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- hypertension, systolic blood pressure, global burden of disease, ischemic heart disease, ischemic stroke, hemorrhagic stroke, disability-adjusted life years, cause-specific mortality, cardiovascular disease, health loss, age and sex differences, spatiotemporal trends, cardiovascular risk factors, 1990-2015 trends
- MeSH terms
- Adult, Aged, Aged, 80 and over, Blood Pressure, Cause of Death, Female, Health Surveys, Humans, Hypertension, Male, Middle Aged, Monte Carlo Method, Systole, Global Health, Prevalence, Normal Distribution, Myocardial Ischemia, Age Distribution, Sex Distribution, Risk Assessment, Quality-Adjusted Life Years, Intracranial Hemorrhages, Stroke, Uncertainty, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review